glp 1 agonist drugs side effects A monthly GLP-1 dose could cut the number of shots patients take each year from 52 to 12. from the drug — mainly gastrointestinal symptoms — were similar to or does glp 1 cause body

Build muscle through strength training

It has multiple actions including: potentiation of glucose-mediated insulin secretion mechanisms identified: increased -cell proliferation, resulting in an increase -cell mass (Fusco et al, 2017) stimulation of insulin biosynthesis at the translational level, helping to maintain -cell insulin stores and secretory capacity (Baggio & Drucker, 2007) because the GLP-1 effect is glucose-dependent (there is more insulin release when glucose levels are elevated, but less effect when glucose levels are normal), GLP-1 agonists have a lower risk for producing hypoglycemia compared to sulfonylureas (that chronically stimulate insulin release, independent of glucose concentration) suppression of postprandial glucagon release Evidence indicates that stimulation of pancreatic cells by GLP-1 increases their glucose sensitivity, resulting in less glucagon release at any glucose level (Baggio & Drucker, 2007)

Efficacy was measured by monitoring changes in glycated hemoglobin (HbA1c) and body weight at week 12

Briefly, upon food intake, L cells in the intestine secrete GLP-1 into the circulation

Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials